This article from the Wall Street Journal examines some of the changes expected as Pfizer unveils its new strategy with its latest chief, Jeffrey Kindler, at the helm. "His plan is likely to involve shedding more jobs and rethinking the way the drug giant develops, makes and markets medicines," according to the story. Analysts are anticipating the new vision to be laid out for the public next Monday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.